Expression and purification of recombinant human tyrosine hydroxylase as a fusion protein in Escherichia coli

Protein Expression and Purification

Volumn 84, Issue 2, 2012, Pages 219-223

  Higgins, Colin A ^a   Vermeer, Lydia M ^a   Doorn, Jonathan A ^a   Roman, David L ^a,b  

^a UNIVERSITY OF IOWA   (United States)

^b UNIVERSITY OF IOWA HOSPITALS AND CLINICS   (United States)

Author keywords

Cloning and purification; Escherichia coli; Human tyrosine hydroxylase

Indexed keywords

HYBRID PROTEIN; TYROSINE 3 MONOOXYGENASE;

ARTICLE; ESCHERICHIA COLI; GENE EXPRESSION; GENETICS; HUMAN; ISOLATION AND PURIFICATION; METABOLISM; METHODOLOGY; MOLECULAR CLONING;

CLONING, MOLECULAR; ESCHERICHIA COLI; GENE EXPRESSION; HUMANS; RECOMBINANT FUSION PROTEINS; TYROSINE 3-MONOOXYGENASE;

ESCHERICHIA COLI;

EID: 84863225427     PISSN: 10465928     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.pep.2012.05.007     Document Type: Article

References (22)

1. J.D. Elsworth, and R.H. Roth Dopamine synthesis, uptake, metabolism, and receptors: relevance to gene therapy of Parkinson's disease Exp. Neurol. 144 1997 4 9
2. T. Nagatsu, M. Levitt, and S. Udenfriend Tyrosine hydroxylase. The Initial step in norepinephrine biosynthesis J. Biol. Chem. 239 1964 2910 2917
3. S.C. Daubner, C. Lauriano, J.W. Haycock, and P.F. Fitzpatrick Site-directed mutagenesis of serine 40 of rat tyrosine hydroxylase. Effects of dopamine and cAMP-dependent phosphorylation on enzyme activity J. Biol. Chem. 267 1992 12639 12646
4. Y. Xu, A.H. Stokes, R. Roskoski Jr., and K.E. Vrana Dopamine, in the presence of tyrosinase, covalently modifies and inactivates tyrosine hydroxylase J. Neurosci. Res. 54 1998 691 697
5. L.M. Mexas, V.R. Florang, and J.A. Doorn Inhibition and covalent modification of tyrosine hydroxylase by 3,4-dihydroxyphenylacetaldehyde, a toxic dopamine metabolite Neurotoxicology 40 2011 471 477
6. J.K. Andersen Oxidative stress in neurodegeneration: cause or consequence? Nat. Med. 10 Suppl 2004 S18 25
7. W.J. Burke, S.W. Li, E.A. Williams, R. Nonneman, and D.S. Zahm 3,4-Dihydroxyphenylacetaldehyde is the toxic dopamine metabolite in vivo: implications for Parkinson's disease pathogenesis Brain Res. 989 2003 205 213
8. W.J. Burke 3,4-dihydroxyphenylacetaldehyde: a potential target for neuroprotective therapy in Parkinson's disease Curr. Drug Targets CNS Neurol. Disord. 2 2003 143 148
9. B. Le Bourdelles, P. Horellou, J.P. Le Caer, P. Denefle, M. Latta, J. Haavik, B. Guibert, J.F. Mayaux, and J. Mallet Phosphorylation of human recombinant tyrosine hydroxylase isoforms 1 and 2: an additional phosphorylated residue in isoform 2, generated through alternative splicing J. Biol. Chem. 266 1991 17124 17130
10. Y.H. Wang, B.A. Citron, P. Ribeiro, and S. Kaufman High-level expression of rat PC12 tyrosine hydroxylase cDNA in Escherichia coli: purification and characterization of the cloned enzyme Proc. Natl. Acad. Sci. USA 88 1991 8779 8783
11. L.G. Gahn, and R. Roskoski Jr. Tyrosine hydroxylase purification from rat PC12 cells Protein Expres. Purif. 2 1991 10 14
12. J. Haavik, B. Le Bourdelles, A. Martinez, T. Flatmark, and J. Mallet Recombinant human tyrosine hydroxylase isozymes. Reconstitution with iron and inhibitory effect of other metal ions Eur. J. Biochem. 199 1991 371 378
13. R. Kristelly, G. Gao, and J.J. Tesmer Structural determinants of RhoA binding and nucleotide exchange in leukemia-associated Rho guanine-nucleotide exchange factor J. Biol. Chem. 279 2004 47352 47362
14. B.J. Olson, J. Markwell, Assays for determination of protein concentration. Curr. Protoc. Protein Sci. Chapter 3 (2007) Unit 3 4.
15. A. Alegria-Schaffer, A. Lodge, and K. Vattem Performing and optimizing Western blots with an emphasis on chemiluminescent detection Methods Enzymol. 463 2009 573 599
16. R.B. Kapust, and D.S. Waugh Escherichia coli maltose-binding protein is uncommonly effective at promoting the solubility of polypeptides to which it is fused Protein Sci. 8 1999 1668 1674
17. R.B. Kapust, J. Tozser, J.D. Fox, D.E. Anderson, S. Cherry, T.D. Copeland, and D.S. Waugh Tobacco etch virus protease: mechanism of autolysis and rational design of stable mutants with wild-type catalytic proficiency Protein Eng. 14 2001 993 1000
18. A. Nakashima, K. Mori, T. Nagatsu, and A. Ota Expression of human tyrosine hydroxylase type I in Escherichia coli as a protease-cleavable fusion protein. Short communication. J. Neural. Transm. 106 1999 819 824
19. D.M. Kuhn, and M.L. Billingsley Tyrosine hydroxylase: purification from PC-12 cells, characterization and production of antibodies Neurochem. Int. 11 1987 463 475
20. K. Kojima, M. Mogi, K. Oka, and T. Nagatsu Purification and immunochemical characterization of human adrenal tyrosine hydroxylase Neurochem. Int. 6 1984 475 480
21. T. Nagatsu, M. Levitt, and S. Udenfriend A rapid and simple radioassay for tyrosine hydroxylase activity Anal. Biochem. 9 1964 122 126
22. P.F. Fitzpatrick Steady-state kinetic mechanism of rat tyrosine hydroxylase Biochemistry 30 1991 3658 3662